FORM N-PX PROXY VOTING RECORD

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 COLUMN 9 COLUMN 10 COLUMN 11 COLUMN 12 COLUMN 13 COLUMN 14 COLUMN 15
NAME   OF   ISSUER
CUSIP ISIN FIGI MEETING   DATE VOTE   DESCRIPTION VOTE   CATEGORY DESCRIPTION   OF   OTHER  CATEGORY VOTE   SOURCE SHARES   VOTED SHARES   ON   LOAN DETAILS   OF   VOTE MANAGER   NUMBER SERIES   ID OTHER   INFO
HOW   VOTED SHARES  VOTED FOR   OR   AGAINST   MANAGEMENT
AKERO THERAPEUTICS INC 00973Y108 - - 06/07/2024 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES
- - 5233989 0 FOR
5233989
FOR
- -
ALIGNMENT HEALTHCARE INC 01625V104 - - 06/07/2024 Approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Named Executive Officers" or "NEOs"). SECTION 14A SAY-ON-PAY VOTES
- - 55803328 0 FOR
55803328
FOR
- -
SQUARESPACE INC 85225A107 - - 06/04/2024 To approve by a non-binding advisory vote the frequency of future advisory votes to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES
- - 5542966 0 FOR
5542966
FOR
- -
CONTEXTLOGIC INC 21077C305 - - 04/12/2024 A proposal to approve, on an advisory, non-binding basis, certain compensation that has, will or may be paid or become payable to the Company's named executive officers in connection with the Asset Sale (the "Advisory Compensation Proposal"); and SECTION 14A SAY-ON-PAY VOTES
- - 609616 0 FOR
609616
FOR
- -
CONTEXTLOGIC INC 21077C305 - - 06/18/2024 To approve, on an advisory basis, our named executive officer compensation for the year ended December 31, 2023, as disclosed herein. SECTION 14A SAY-ON-PAY VOTES
- - 0 0 NO VOTE CAST
0
AGAINST
- -
IMMUNOCORE HLDGS PLC 45258D105 - - 05/23/2024 To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the attached proxy statement. SECTION 14A SAY-ON-PAY VOTES
- - 1506684 0 FOR
1506684
FOR
- -
IMMUNOCORE HLDGS PLC 45258D105 - - 05/23/2024 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
- - 1506684 0 FOR
1506684
FOR
- -
KARUNA THERAPEUTICS, INC. 48576A100 - - 03/12/2024 To consider and vote on a proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger (the "named executive officer merger-related compensation proposal"); SECTION 14A SAY-ON-PAY VOTES
- - 986710 0 FOR
986710
FOR
- -
MOBILEYE GLOBAL INC 60741F104 - - 06/13/2024 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES
- - 1194839 0 FOR
1194839
FOR
- -
OPENDOOR TECHNOLOGIES INC 683712103 - - 06/14/2024 The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES
- - 6321519 0 FOR
6321519
FOR
- -
ROYALTY PHARMA PLC G7709Q104 - - 06/06/2024 Approve on a non-binding advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
- - 2055039 0 FOR
2055039
FOR
- -
SQUARESPACE INC 85225A107 - - 06/04/2024 To approve by a non-binding advisory vote the compensation of our named executive officers, as disclosed in this proxy statement; SECTION 14A SAY-ON-PAY VOTES
- - 5542966 0 FOR
5542966
FOR
- -

[Repeat as Necessary]